Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Current Assets

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Current Assets ₹11,300 Cr₹9,295 Cr₹7,428 Cr₹8,424 Cr₹8,282 Cr

What is the latest Total Current Assets ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Current Assets ratio of GLENMARK PHARMACEUTICALS is ₹11,300 Cr based on Mar2026 Consolidated results.
Year Total Current Assets
Mar2026₹11,300 Cr
Mar2025₹9,295 Cr
Mar2024₹7,428 Cr
Mar2023₹8,424 Cr
Mar2022₹8,282 Cr

How is Total Current Assets of GLENMARK PHARMACEUTICALS Trending?

Years Total Current Assets % Change
Mar2026 ₹11,300 Cr
21.56
Mar2025 ₹9,295 Cr
25.14
Mar2024 ₹7,428 Cr
-11.82
Mar2023 ₹8,424 Cr
1.71
Mar2022 ₹8,282 Cr -

Compare Total Current Assets of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹68,856.8 Cr 5% 11.7% 24.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,114.0 Cr NA -3.9% 17.3% Stock Analytics
DIVIS LABORATORIES ₹239,321.0 Cr 5% 21.5% 44.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,924.0 Cr -2.1% -0.2% 34.3% Stock Analytics
CIPLA ₹113,778.0 Cr -2% -2.5% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹99,025.9 Cr 0.4% 4.5% -4.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

5%

11.7%

24.6%

SENSEX

0.7%

0.8%

-5.1%


You may also like the below Video Courses